{"version":"1.0","type":"link","title":"Artemisinin sensitizes triple negative breast cancer to immune checkpoint therapy through suppressing KEAP1-mediated PD-L1 degradation.","author_name":"He Z 외","author_url":"https://prs-insight.online/author/He%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/83228","thumbnail_width":1200,"thumbnail_height":630}